{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:07:20Z","timestamp":1790381240621,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,2,7]],"date-time":"2020-02-07T00:00:00Z","timestamp":1581033600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Anais Brasileiros de Dermatologia"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/j.abd.2019.07.006","type":"journal-article","created":{"date-parts":[[2020,2,12]],"date-time":"2020-02-12T06:23:12Z","timestamp":1581488592000},"page":"165-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1975-7460","authenticated-orcid":false,"given":"Efsun","family":"Tanacan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3700-514X","authenticated-orcid":false,"given":"Nilgun","family":"Atakan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.abd.2019.07.006_bib0155","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.abd.2019.07.006_bib0160","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1111\/j.1365-4632.2011.05377.x","article-title":"A review of the worldwide prevalence of vitiligo in children\/adolescents and adults","volume":"51","author":"Kr\u00fcger","year":"2012","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0165","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1600-0749.2003.00032.x","article-title":"Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families","volume":"16","author":"Alkhateeb","year":"2003","journal-title":"Pigment Cell Res"},{"key":"10.1016\/j.abd.2019.07.006_bib0170","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1111\/j.1365-4632.2009.03770.x","article-title":"Case detection rates of vitiligo by gender and age","volume":"48","author":"Kyriakis","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0175","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.jaad.2010.11.061","article-title":"Vitiligo: a comprehensive overview: part I Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up","volume":"65","author":"Alikhan","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0180","doi-asserted-by":"crossref","first-page":"89","DOI":"10.9790\/0853-150798999","article-title":"Scoring system in dermatology: a review","volume":"15","author":"Lakhani","year":"2016","journal-title":"IOSR"},{"key":"10.1016\/j.abd.2019.07.006_bib0185","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.autrev.2015.12.006","article-title":"Vitiligo: pathogenesis, clinical variants and treatment approaches","volume":"15","author":"Iannella","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.abd.2019.07.006_bib0190","series-title":"International Diabetes Federation: The IDF consensus worldwide definition of the metabolic syndrome [Internet]","author":"Group IETFC","year":"2005"},{"key":"10.1016\/j.abd.2019.07.006_bib0195","doi-asserted-by":"crossref","first-page":"943162","DOI":"10.1155\/2014\/943162","article-title":"A comprehensive review on metabolic syndrome","volume":"2014","author":"Kaur","year":"2014","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/j.abd.2019.07.006_bib0200","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.autrev.2014.07.001","article-title":"Obesity in autoimmune diseases: not a passive bystander","volume":"13","author":"Versini","year":"2014","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.abd.2019.07.006_bib0205","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1111\/dth.12012","article-title":"Metabolic syndrome in vitiligo","volume":"25","author":"Pietrzak","year":"2012","journal-title":"Dermatol Therapy"},{"key":"10.1016\/j.abd.2019.07.006_bib0210","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/j.1365-2133.2007.07986.x","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control study","volume":"157","author":"Gisondi","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0215","doi-asserted-by":"crossref","first-page":"219","DOI":"10.4274\/balkanmedj.2016.1005","article-title":"Increased risk of metabolic syndrome in patients with vitiligo","volume":"34","author":"Ata\u015f","year":"2017","journal-title":"Balkan Med J"},{"key":"10.1016\/j.abd.2019.07.006_bib0220","first-page":"307","article-title":"Metabolic syndrome and skin diseases","volume":"147","author":"Svacina","year":"2008","journal-title":"Europe PMC Plus"},{"key":"10.1016\/j.abd.2019.07.006_bib0225","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00403-006-0703-z","article-title":"Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasis","volume":"298","author":"Sommer","year":"2007","journal-title":"Arch Dermatol Res"},{"key":"10.1016\/j.abd.2019.07.006_bib0230","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/jid.2011.365","article-title":"Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom","volume":"132","author":"Langan","year":"2012","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0235","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/j.dsx.2016.12.009","article-title":"Metabolic syndrome in vitiligo patients among a semi-urban Maharashtrian population: a case control study","volume":"11","author":"Sharma","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.abd.2019.07.006_bib0240","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1365-2230.2011.04142.x","article-title":"Serum holotranscobalamine, vitamin B12, folic acid and homocysteine levels in patients with vitiligo","volume":"37","author":"Karadag","year":"2012","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0245","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.det.2016.11.012","article-title":"The role of diet and supplements in vitiligo management","volume":"35","author":"Grimes","year":"2017","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.abd.2019.07.006_bib0250","doi-asserted-by":"crossref","first-page":"65","DOI":"10.4103\/1110-6530.137315","article-title":"Serum levels of homocysteine, vitamin B12, and folic acid in vitiligo","volume":"34","author":"Sabry","year":"2014","journal-title":"Egypt J Dermatol Venerol"},{"key":"10.1016\/j.abd.2019.07.006_bib0255","first-page":"13","article-title":"Definition of metabolic syndrome: report of the National Heart Lung, and Blood Institute\/American Heart Association conference on scientific issues related to definition","volume":"24","author":"Grundy","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.abd.2019.07.006_bib0260","first-page":"31","article-title":"The IDF consensus worldwide definition of the metabolic syndrome","volume":"50","author":"Zimmet","year":"2005","journal-title":"Diabetes Voice"},{"key":"10.1016\/j.abd.2019.07.006_bib0265","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-2230.2009.03765.x","article-title":"Vitiligo is more than skin deep: a survey of members of the Vitiligo Society","volume":"35","author":"Talsania","year":"2010","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0270","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2340\/00015555-1141","article-title":"Insulin resistance is increased in patients with vitiligo","volume":"91","author":"Karadag","year":"2011","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.abd.2019.07.006_bib0275","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.jaad.2010.08.025","article-title":"Serum homocysteine as a biomarker of vitiligo vulgaris severity: a pilot study","volume":"64","author":"Silverberg","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.abd.2019.07.006_bib0280","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1111\/j.1467-789X.2010.00773.x","article-title":"Melanin and melanogenesis in adipose tissue: possible mechanisms for abating oxidative stress and inflammation?","volume":"12","author":"Page","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/j.abd.2019.07.006_bib0285","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fj.08-116327","article-title":"Evidence for the ectopic synthesis of melanin in human adipose tissue","volume":"23","author":"Randhawa","year":"2009","journal-title":"FASEB J"},{"key":"10.1016\/j.abd.2019.07.006_bib0290","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1365-2265.2004.02056.x","article-title":"Plasma concentrations of alpha-MSH AgRP and leptin in lean and obese men and their relationship to differing states of energy balance perturbation","volume":"61","author":"Hoggard","year":"2004","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.abd.2019.07.006_bib0295","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/oby.2007.525","article-title":"Expression and localization of melanocortin-1 receptor in human adipose tissues of severely obese patients","volume":"15","author":"Hoch","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.abd.2019.07.006_bib0300","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1476-511X-3-7","article-title":"Positive pleiotropic effects of HMG-CoA reductase inhibitor on vitiligo","volume":"3","author":"No\u00ebl","year":"2004","journal-title":"Lipids Health Dis"}],"container-title":["Anais Brasileiros de Dermatologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620300374?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0365059620300374?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T06:33:14Z","timestamp":1754461994000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0365059620300374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S0365059620300374"],"URL":"https:\/\/doi.org\/10.1016\/j.abd.2019.07.006","relation":{},"ISSN":["0365-0596"],"issn-type":[{"value":"0365-0596","type":"print"}],"subject":[],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Higher incidence of metabolic syndrome components in vitiligo patients: a prospective cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"Anais Brasileiros de Dermatologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.abd.2019.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Sociedade Brasileira de Dermatologia. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}